Ameriprise Financial Valuation
Is AMP * undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
3/6Valuation Score 3/6
Below Fair Value
Significantly Below Fair Value
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of AMP * when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: AMP * (MX$7990) is trading below our estimate of fair value (MX$11254.44)
Significantly Below Fair Value: AMP * is trading below fair value by more than 20%.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for AMP *?
Other financial metrics that can be useful for relative valuation.
What is AMP *'s n/a Ratio? | |
---|---|
n/a | 0x |
n/a | n/a |
Market Cap | US$42.74b |
Key Statistics | |
---|---|
Enterprise Value/Revenue | 2.4x |
Enterprise Value/EBITDA | 7.4x |
PEG Ratio | 3.6x |
Price to Earnings Ratio vs Peers
How does AMP *'s PE Ratio compare to its peers?
Company | Forward PE | Estimated Growth | Market Cap |
---|---|---|---|
Peer Average | 40.7x | ||
GBM O Corporativo GBM. de | 75.8x | n/a | Mex$21.6b |
GPROFUT * Grupo Profuturo. de | 9.5x | n/a | Mex$27.1b |
BK Bank of New York Mellon | 14.4x | 10.1% | US$43.9b |
ARES Ares Management | 63x | 29.7% | US$42.3b |
AMP * Ameriprise Financial | 13.7x | 3.8% | Mex$43.1b |
Price-To-Earnings vs Peers: AMP * is good value based on its Price-To-Earnings Ratio (13.6x) compared to the peer average (40.4x).
Price to Earnings Ratio vs Industry
How does AMP *'s PE Ratio compare vs other companies in the South American Capital Markets Industry?
Price-To-Earnings vs Industry: AMP * is expensive based on its Price-To-Earnings Ratio (13.6x) compared to the South American Capital Markets industry average (10.1x).
Price to Earnings Ratio vs Fair Ratio
What is AMP *'s PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
Fair Ratio | |
---|---|
Current PE Ratio | 13.6x |
Fair PE Ratio | n/a |
Price-To-Earnings vs Fair Ratio: Insufficient data to calculate AMP *'s Price-To-Earnings Fair Ratio for valuation analysis.
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Date | Share Price | Average 1Y Price Target | Dispersion | High | Low | 1Y Actual price | Analysts |
---|---|---|---|---|---|---|---|
Current | Mex$7,990.00 | Mex$8,475.78 +6.1% | 6.5% | Mex$9,162.10 | Mex$7,146.44 | n/a | 11 |
Jun ’25 | Mex$7,319.43 | Mex$7,710.36 +5.3% | 6.5% | Mex$8,334.70 | Mex$6,501.07 | n/a | 11 |
May ’25 | n/a | Mex$7,782.13 0% | 8.2% | Mex$8,573.30 | Mex$6,366.53 | n/a | 12 |
Apr ’25 | Mex$7,341.00 | Mex$7,102.27 -3.3% | 9.3% | Mex$8,085.38 | Mex$5,964.62 | n/a | 11 |
Mar ’25 | Mex$6,973.95 | Mex$7,220.25 +3.5% | 7.9% | Mex$8,165.99 | Mex$6,137.28 | n/a | 12 |
Feb ’25 | Mex$6,713.83 | Mex$7,138.41 +6.3% | 7.8% | Mex$7,784.57 | Mex$6,200.10 | n/a | 11 |
Jan ’25 | n/a | Mex$6,392.39 0% | 6.0% | Mex$6,965.33 | Mex$5,521.30 | n/a | 12 |
Dec ’24 | Mex$6,122.00 | Mex$6,450.77 +5.4% | 7.4% | Mex$7,096.53 | Mex$5,192.58 | n/a | 12 |
Nov ’24 | Mex$5,603.22 | Mex$6,719.82 +19.9% | 7.9% | Mex$7,423.67 | Mex$5,431.95 | n/a | 11 |
Oct ’24 | n/a | Mex$6,588.63 0% | 8.5% | Mex$7,197.63 | Mex$5,266.56 | n/a | 11 |
Sep ’24 | n/a | Mex$6,369.58 0% | 8.6% | Mex$6,987.79 | Mex$5,113.02 | n/a | 11 |
Aug ’24 | Mex$5,813.35 | Mex$6,242.62 +7.4% | 8.8% | Mex$6,865.20 | Mex$5,023.32 | n/a | 11 |
Jul ’24 | n/a | Mex$6,156.08 0% | 9.3% | Mex$6,847.68 | Mex$4,781.42 | n/a | 10 |
Jun ’24 | Mex$5,441.26 | Mex$6,362.52 +16.9% | 9.6% | Mex$7,252.24 | Mex$4,952.75 | Mex$7,319.43 | 10 |
May ’24 | n/a | Mex$6,482.00 0% | 9.3% | Mex$7,350.73 | Mex$5,020.01 | n/a | 11 |
Apr ’24 | n/a | Mex$6,699.03 0% | 11.5% | Mex$7,837.35 | Mex$5,103.39 | Mex$7,341.00 | 11 |
Mar ’24 | n/a | Mex$6,998.11 0% | 10.2% | Mex$8,007.03 | Mex$5,344.23 | Mex$6,973.95 | 11 |
Feb ’24 | Mex$6,563.00 | Mex$6,998.11 +6.6% | 10.2% | Mex$8,007.03 | Mex$5,344.23 | Mex$6,713.83 | 11 |
Jan ’24 | Mex$6,085.00 | Mex$6,624.97 +8.9% | 6.8% | Mex$7,378.73 | Mex$5,572.88 | n/a | 11 |
Dec ’23 | Mex$6,355.62 | Mex$6,624.97 +4.2% | 6.8% | Mex$7,378.73 | Mex$5,572.88 | Mex$6,122.00 | 11 |
Nov ’23 | Mex$5,836.57 | Mex$6,497.94 +11.3% | 7.2% | Mex$7,280.66 | Mex$5,693.59 | Mex$5,603.22 | 11 |
Oct ’23 | n/a | Mex$6,237.44 0% | 9.8% | Mex$6,806.81 | Mex$4,833.24 | n/a | 11 |
Sep ’23 | n/a | Mex$6,168.42 0% | 9.5% | Mex$6,800.15 | Mex$4,828.51 | n/a | 10 |
Aug ’23 | n/a | Mex$6,089.29 0% | 9.7% | Mex$6,889.83 | Mex$4,892.18 | Mex$5,813.35 | 11 |
Jul ’23 | Mex$4,780.25 | Mex$6,454.48 +35.0% | 12.3% | Mex$7,319.09 | Mex$5,087.17 | n/a | 11 |
Jun ’23 | Mex$5,051.37 | Mex$6,641.87 +31.5% | 6.6% | Mex$7,172.07 | Mex$5,418.46 | Mex$5,441.26 | 11 |
Analyst Forecast: Target price is less than 20% higher than the current share price.